000 01473 a2200397 4500
005 20250516161932.0
264 0 _c20131029
008 201310s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/jm4007565
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHen, Naama
245 0 0 _aStereoselective pharmacodynamic and pharmacokinetic analysis of sec-Butylpropylacetamide (SPD), a new CNS-active derivative of valproic acid with unique activity against status epilepticus.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cAug 2013
300 _a6467-77 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetamides
_xpharmacokinetics
650 0 4 _aAmides
650 0 4 _aAnimals
650 0 4 _aAnticonvulsants
_xpharmacokinetics
650 0 4 _aDisease Models, Animal
650 0 4 _aRats
650 0 4 _aSoman
_xantagonists & inhibitors
650 0 4 _aStatus Epilepticus
_xdrug therapy
650 0 4 _aStereoisomerism
650 0 4 _aTeratogens
_xtoxicity
650 0 4 _aValproic Acid
_xpharmacokinetics
700 1 _aShekh-Ahmad, Tawfeeq
700 1 _aYagen, Boris
700 1 _aMcDonough, John H
700 1 _aFinnell, Richard H
700 1 _aWlodarczyk, Bogdan
700 1 _aBialer, Meir
773 0 _tJournal of medicinal chemistry
_gvol. 56
_gno. 16
_gp. 6467-77
856 4 0 _uhttps://doi.org/10.1021/jm4007565
_zAvailable from publisher's website
999 _c22941115
_d22941115